Our Pricing

Buy Wegovy Online UK Private Prescription

Published on: June 03, 2026

Looking to buy Wegovy online UK private prescription without the wait? At Cured Pharmacy, you can access genuine UK-licensed Wegovy (semaglutide) injections from £79.00 with a free online consultation completed in under 3 minutes. Our UK-registered prescribers assess your suitability without requiring a GP referral, and we deliver discreetly to your door with transparent upfront pricing.

How Wegovy Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity [1]. Semaglutide mimics a natural hormone that regulates appetite and food intake, helping you feel fuller for longer and reducing cravings between meals.

In the landmark STEP 1 clinical trial, participants using Wegovy alongside lifestyle modifications achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. This represents one of the most significant weight loss outcomes seen in any pharmacological obesity trial to date, demonstrating the effectiveness of semaglutide when combined with a reduced-calorie diet and increased physical activity.

Why Choose Cured Pharmacy for Your Wegovy Private Prescription

At Cured Pharmacy, we've streamlined the process of accessing weight loss medication online. Our service is designed for UK patients who value convenience, transparency, and clinical expertise without the typical delays associated with traditional GP appointments.

Every consultation is reviewed by our UK-registered clinical team led by superintendent pharmacist Tarun Kumar (GPhC 2233073). We provide transparent upfront pricing with Wegovy available from £79.00 significantly lower than typical market rates. You'll see the exact cost before completing your clinical assessment, with no hidden fees or surprise charges at checkout.

We're a fully registered UK pharmacy (GPhC 9012511) dispensing only genuine, UK-licensed medicines. Your medication arrives in 100% discreet packaging, and our clinical team is available on (+44) 116 4646009 if you have questions about your treatment.

No GP Referral Required

Unlike NHS pathways that may require months of waiting and multiple GP appointments, our private prescription service allows you to start your weight loss journey immediately. Our UK prescribers conduct a comprehensive clinical assessment online, reviewing your medical history, current medications, and weight loss goals to determine if Wegovy is appropriate for you. Subject to prescriber approval, your medication can be dispensed and dispatched the same day.

Wegovy Dosing Schedule and What to Expect

Wegovy follows a carefully structured dose escalation schedule designed to minimise gastrointestinal side effects whilst optimising weight loss outcomes [2]. You'll start with a 0.25 mg injection once weekly for the first four weeks, gradually increasing every four weeks through 0.5 mg, 1 mg, and 1.7 mg doses before reaching the maintenance dose of 2.4 mg weekly.

This gradual titration approach, validated in clinical trials, allows your body to adapt to the medication whilst reducing the likelihood of nausea, vomiting, and diarrhoea — the most commonly reported side effects in the STEP programme [2]. Most patients find these effects mild to moderate and diminishing over time as they progress through the dose schedule.

Administering Your Weekly Injection

Wegovy comes in a pre-filled, single-use pen that's designed for self-injection into the abdomen, thigh, or upper arm. Each pen contains one dose, and you'll inject subcutaneously (under the skin) once per week on the same day each week. The injection process takes less than a minute, and most patients report minimal discomfort. Your first prescription will include detailed instructions, and our pharmacy team can provide additional guidance if needed.

Who Can Use Wegovy: Eligibility Criteria

Wegovy is licensed in the UK for adults aged 18 and over with an initial BMI of 30 kg/m² or greater (obesity), or 27 kg/m² or greater (overweight) in the presence of at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [1]. Your prescriber will calculate your BMI during the online consultation and assess whether you meet these clinical criteria.

Certain medical conditions may make Wegovy unsuitable. You should not use semaglutide if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, severe gastrointestinal disease, or if you're pregnant, breastfeeding, or planning pregnancy [3]. Your online assessment will screen for these contraindications, and our prescribers may recommend alternative treatments if Wegovy isn't appropriate for your circumstances.

Wegovy Side Effects and Safety Considerations

The most frequently reported side effects of Wegovy in clinical trials were gastrointestinal in nature, including nausea (44% of participants), diarrhoea (30%), vomiting (24%), and constipation (24%) [2]. These effects were typically mild to moderate in severity and decreased over time as patients progressed through dose escalation. Taking Wegovy with food and staying well-hydrated can help manage these symptoms.

Less common but more serious side effects may include pancreatitis, gallbladder problems, kidney injury, and changes in vision in patients with type 2 diabetes [3]. If you experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction such as swelling of the face or throat, you should seek immediate medical attention and discontinue use until assessed by a healthcare professional.

Regular monitoring by your prescriber is essential. At Cured Pharmacy, we recommend follow-up consultations every 12 weeks to assess your progress, review any side effects, and adjust your treatment plan as needed. Your prescriber will evaluate whether you're achieving meaningful weight loss (typically defined as at least 5% body weight reduction after 12-16 weeks) and determine if continued treatment is appropriate.

Drug Interactions and Precautions

Wegovy may interact with certain medications, particularly those that affect blood sugar levels. If you're taking insulin or sulfonylureas for diabetes, your prescriber may need to adjust these doses to reduce the risk of hypoglycaemia. Semaglutide also delays gastric emptying, which can affect the absorption of oral medications [3]. Always inform your prescriber of all medications, supplements, and herbal products you're currently taking during your online consultation.

Combining Wegovy with Lifestyle Modifications

Wegovy is most effective when used as part of a comprehensive weight management programme that includes a reduced-calorie diet and increased physical activity [1]. In clinical trials, participants received counselling on lifestyle modifications alongside medication, and this combined approach produced significantly greater weight loss than either intervention alone.

NICE guidance recommends that patients using GLP-1 receptor agonists for weight management should engage with structured diet and exercise programmes to optimise outcomes and develop sustainable healthy behaviours [4]. At Cured Pharmacy, whilst we provide the medication and clinical oversight, we encourage all patients to work with registered dietitians or weight management services to develop personalised nutrition and activity plans that support long-term success.

Weight loss achieved with Wegovy may begin to plateau after 60-68 weeks of treatment [1]. Maintaining weight loss after discontinuation requires ongoing commitment to the lifestyle changes established during treatment. Some patients may experience weight regain after stopping semaglutide, which is why developing sustainable habits throughout your treatment journey is crucial for lasting results.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., ... & Wadden, T. A. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4 [accessed 13 August 2026]
3. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity: Technology appraisal guidance [TA875]. NICE. Retrieved from https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine and individual results may vary. Weight loss outcomes depend on adherence to treatment and lifestyle modifications.